Congress Widens J&J Probe To Include Contractors
5 CommentsBy Ed Silverman // June 4th, 2010 // 6:32 am
The Congressional committee investigating the J&J recall scandal is now looking at two contractors that were hired by the healthcare giant to retrieve defective Motrin tablets from stores in what is being called a “phantom recall.” The move comes after a hearing last week in which it was learned employees were instructed not to discuss a possible recall (see this memo).
In a letter to the contractors, the House Committee on Oversight & Government Reform is seeking info about their relationships with Johnson & Johnson and details of their activities. The letters allege the contractors - WIS and Carolina Supply Chain Services ( see the letter here and here) - secretly purchased Motrin bottles in order to avoid issuing a formal recall, but J&J announced a recall after the FDA discovered the “covert activity.” Since then, a Fort Washington, Pa., plant run by J&J’s McNeil Consumer Healthcare unit has been closed to rectify quality-control problems found by the FDA (see the FDA report). J&J recalled dozens of products, including Children’s Tylenol.
“Rather than doing the right thing and announcing a recall, we have learned that the drug company hired contractors to basically sneak into stores to purchase the products as if they were legitimate customers,” committee chair Ed Towns says in a statement. “We need to better understand Johnson & Johnson’s relationship with the contractor and get to the bottom of the services the contractor was asked to provide. It wasn’t until this caper was foiled by the FDA that McNeil did what it should have done in the first place and recalled the affected medication. The company’s motivation was apparently to save itself the embarrassment and potential financial loss associated with a recall.”
So far, the committee has received more than 20,000 documents from J&J and McNeil, and committee investigators have interviewed top McNeil exec, including the president of McNeil, as well as top FDA officials, according to a source close to the investigation. The committee has also received more than 1,000 documents from the FDA. Meanwhile, on its web site, WIS brags…
that “when a product recall occurs, manufacturers need a qualified partner with a national workforce that can rapidly visit many sites over a short period of time. WIS can assist in quickly removing recalled items from each site, package product for shipment and documenting returns. WIS International has executed product recalls projects ranging from a few hundred sites to thousands of locations. Count on WIS International when a rapid response is required!”
WIS clients listed include Home Depot; Walmart; Loblaws; Dollar General Stores; Safeway; Bath & Body Works; JC Penney; Lowes Hardware; Rite Aid; Walgreens and Office Depot. Carolina Supply Chain Services is now owned by Inmar, which is owned by New Mountain Capital (see this), a private equity firm. UPDATE: Inmar’s marketing vp, Sharon Joyner-Payne, writes us to say that: “We will review the committee’s request and respond and comply with all questions.”
Vice-President Marketing
Sharon Joyner-Payne
Vice-President Marketing
Former Pharma Marketing Director
The person (s) who came up with this plan at J&J should have charges brought against them. The upper management that okayed this plan are just as guilty. I hope if there is anyone in good standing left at J&J that they do a complete overhaul.
Didn’t they realize that the public would have admired them much more, and they probably wouldn’t lose customers if they would have just owned up to the situation in the first place?
It will be interesting to watch what and how the operations screwed up so much on the quality control.
No more J&J products for me - not to punish J&J, but to send a signal to others that they need to get their house in order…Hope more people boycott them as well!
AnneS
Lovely
“Rather than doing the right thing and announcing a recall, we have learned that the drug company hired contractors to basically sneak into stores to purchase the products as if they were legitimate customers”
With all the recalls, conflicts of interests, ghost-written papers, etc do people really still think pharmaceutical companies care about people’s health?
M. Black
It needs attention from people like yourself to not cause trouble for a manufacturing unit. But it’s people like you to ensure a company that throws caution to the wind to throw the marbles in their path IF the situation warrants it.
MB
Ace 1 in the hole
These people that provides audits give WAY too much leadway (i.e. Time to
shred documents and reprint internal data that was ::ahem:: reprinted.
Yes there are pharmaceutical GMP’s that the heads of Quality should follow. One of the ways this is done is to provide regular and current GMP’s.
30 years is not “current”
FAIL
Straightshooter
Are you seriously surprised…those of us in the industry can tell you of plenty of stories like this…FDA visits where there are virtually no cGMP or SOPs being followed and the site gets a clean bill of health…the FDA is a sham unless the media gets involved…
cummon people, this is big business and big money…why act surprised…this is the norm…you know it, i know it…its only those who dont work in pharma who are clueless…
i hate the lies and this industry…none of them care about the consumer…just mo-money—mo money…
but i will feign surprise and indignation…
Oh my , how horrible…i hope they pay for this…